Federal health regulators said late Friday that kid-size doses of Pfizer's COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters.
from Section Page News - Modern Healthcare https://ift.tt/3CfjB67
No comments:
Post a Comment